Long-term memory B-cell responses in recipients of candidate human immunodeficiency virus type 1 vaccines
- 30 June 2004
- Vol. 22 (20) , 2626-2630
- https://doi.org/10.1016/j.vaccine.2003.12.011
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Viremia Control Despite Escape from a Rapid and Potent Autologous Neutralizing Antibody Response After Therapy Cessation in an HIV-1-Infected IndividualThe Journal of Immunology, 2003
- Prospects for Vaccine Protection Against HIV-1 Infection and AIDSAnnual Review of Immunology, 2002
- Antibody Protects Macaques against Vaginal Challenge with a Pathogenic R5 Simian/Human Immunodeficiency Virus at Serum Levels Giving Complete Neutralization In VitroJournal of Virology, 2001
- Human neutralizing monoclonal antibodies of the IgG1 subtype protect against mucosal simian–human immunodeficiency virus infectionNature Medicine, 2000
- Protection of macaques against vaginal transmission of a pathogenic HIV-1/SIV chimeric virus by passive infusion of neutralizing antibodiesNature Medicine, 2000
- Neutralizing antibody directed against the HIV–1 envelope glycoprotein can completely block HIV–1/SIV chimeric virus infections of macaque monkeysNature Medicine, 1999
- Neutralizing Antibodies Administered Before, but Not After, Virulent SHIV Prevent Infection in MacaquesAIDS Research and Human Retroviruses, 1998
- The HIV-1 Envelope Glycoproteins: Fusogens, Antigens, and ImmunogensScience, 1998
- Passive immune globulin therapy in the SIV/macaque model: early intervention can alter disease profileImmunology Letters, 1996
- Immunization with Envelope Subunit Vaccine Products Elicits Neutralizing Antibodies against Laboratory-Adapted but Not Primary Isolates of Human Immunodeficiency Virus Type 1The Journal of Infectious Diseases, 1996